CLPTM1L and lung carcinoma: Future investigations should aim to elucidate the underlying mechanisms, taking into account factors such as histology or race heterogeneity, to provide a more nuanced understanding of the impact of CLPTM1L gene polymorphism on lung cancer risk and to tailor personal therapy.